Agape ATP Corp

Sign in to save

Sign in to set an alert

Tickers: ATPC
Headquarters: Not recorded
SEC CIK: 0001713210
Website: Not recorded

Closing prices

Too many attempts. Please wait a minute and try again.

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

Too many attempts. Please wait a minute and try again.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

Too many attempts. Please wait a minute and try again.

SEC filings

SEC filings from Agape ATP Corp, newest first
Form	Filed	What it covers	Document
10-Q	14 Aug 2026Event 30 Jun 2026	Quarterly report (10-Q)	View Quarterly report (10-Q) filed 14 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-037992 (opens in a new tab)
S-1/A	20 Jul 2026	Form S-1/A	View Form S-1/A filed 20 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-033881 (opens in a new tab)
S-1	8 Jun 2026	Form S-1	View Form S-1 filed 8 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-027669 (opens in a new tab)
10-Q	15 May 2026Event 31 Mar 2026	Quarterly report (10-Q)	View Quarterly report (10-Q) filed 15 May 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-023388 (opens in a new tab)
10-K	13 Apr 2026Event 31 Dec 2025	Annual report (10-K)	View Annual report (10-K) filed 13 Apr 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-016297 (opens in a new tab)
8-K	12 Mar 2026	Current report (8-K) Notice of delisting or listing rule failure (Item 3.01)	View Current report (8-K) filed 12 Mar 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-009790 (opens in a new tab)
8-K	10 Mar 2026	Current report (8-K) Entry into a material definitive agreement (Item 1.01) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 10 Mar 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-009469 (opens in a new tab)
S-3	6 Feb 2026	Registration statement (S-3)	View Registration statement (S-3) filed 6 Feb 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-005495 (opens in a new tab)
8-K	6 Feb 2026	Current report (8-K) Material modification to rights of security holders (Item 3.03) Amendments to articles or bylaws; change in fiscal year (Item 5.03) Regulation FD disclosure (Item 7.01) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 6 Feb 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-005471 (opens in a new tab)
8-K	5 Feb 2026	Current report (8-K) Notice of delisting or listing rule failure (Item 3.01) Regulation FD disclosure (Item 7.01) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 5 Feb 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-005211 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P: None in this period
Sells code S: None in this period
Other all other codes: None in this period

Last transaction: none stored

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Editor source (opens in a new tab) Licence: editorial. Entered by an editor, not fetched automatically
SEC EDGAR submissions (opens in a new tab) Licence: public-domain. Fetched 25 Oct 2026

Nothing on this page is investment advice.